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Randomized controlled trials are the prevailing paradigms of  clinical research, and surgical evacuation of intracere-
bral hematomas (ICHs) has been the subject of 16. 1–16 The more 
powerful trials and meta-analyses9,11,17,18 have repeatedly failed to 
displace the null hypothesis though have often shown nonsignifi-
cant benefits. That notwithstanding, there is an ongoing interest in 
the question with further trials ongoing or planned (MISTIE III 
[Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage 
Evacuation], CLEAR IV [Clot Lysis: Evaluating Accelerated 
Resolution of Intraventricular Hemorrhage], and STITCH III 
[International Surgical Trial in IntraCerebral Haemorrhage]).
The null results of trials and meta-analyses led to the hy-
pothesis that the effect of surgery, if any, is too small to detect 
with current trial data. The amount of randomized data now in 
hand has limited the size of such an overall benefit to the ex-
tent that, were it there, it would be of doubtful clinical signif-
icance. These analyses used an assumption common to much 
clinical research: there is a uniform response to a treatment 
for the population under study. This assumption is particu-
larly weak with surgical treatments because in addition to the 
patient-specific variables that affect medical treatments, there 
is also variation between surgeons. Mechanistic lines of ar-
gument have led to a different theory, one commonly held by 
surgeons and one that predates all trial data. This theory is 
that response to surgery is not uniform from one case of ICH 
to another but varies with clot volume and clinical condition.
Background and Purpose—The STICH (Surgical Trial in Lobar Intracerebral Haemorrhage) I and II trials randomized patients 
with spontaneous intracerebral hemorrhage (ICH) to early surgery or initial conservative treatment. Both were nonsignificant; 
possibly because surgery has minimal effect on recovery, or because surgery benefits some and harms others. We introduce a 
new nonparametric method of analysis. The method is then applied to data from a third trial, STITCH(Trauma) (Surgical Trial 
in Traumatic Intracerebral Haemorrhage), which addressed a similar surgical question in head-injured patients.
Methods—Data from 1541 patients from the STICH trials were analyzed using (1) standard meta-analysis of prognosis-
based dichotomized outcome and prespecified standard subgroups of Glasgow Coma Scale (GCS): 3–8, 9–12, and 13–15; 
(2) new nonparametric regression of ranked Extended Glasgow Outcome Scale against ranked GCS and ranked volume; 
and (3) analysis (1) repeated using categories identified by analysis (2).
Results—Standard meta-analysis showed more favorable outcomes, although nonsignificant, with surgery if presenting GCS 
was 9–12 (spontaneous ICH odds ratio, 0.70 [95% CI, 0.48–1.03; P=0.07]; traumatic odds ratio, 0.48 [95% CI, 0.18–
1.26; P=0.14]). Ranked analysis showed a similar pattern of results for both spontaneous and traumatic ICH. Surgery 
was harmful for small lesions with increasing benefit for larger volumes. With GCS, surgery had little effect at either 
ends of the spectrum but suggested a beneficial effect in the range 10 to 13 (identified graphically). Repeating the meta-
analysis with this categorization showed significant benefit for surgery (spontaneous odds ratio, 0.71 [95% CI, 0.51–1.00; 
P=0.05]; traumatic odds ratio, 0.16 [95% CI, 0.05–0.51; P=0.002]).
Conclusions—The nonsignificant results observed in the STICH trials are because of mixing patients who benefit from 
surgery with those who are harmed. Patients with a GCS 10–13 or a large ICH are likely to benefit from surgery. Our 
analysis showed a similar effect on traumatic ICH/contusion data and promises to be a valuable tool.
Clinical Trial Registration—URL: http://www.isrctn.com/. Unique identifiers: ISRCTN19976990 (STITCH), 
ISRCTN22153967 (STICH II), and ISRCTN19321911 (STITCH[Trauma]).   (Stroke. 2019;50:1108-1115. DOI: 
10.1161/STROKEAHA.118.022694.)
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In this article, we present a combined analysis of trial data 
specifically aimed at testing the hypothesis: Is the neutrality of 
trial data a consequence of little effect or a consequence of mix-
ing cases who benefit from surgery with those that are harmed?
Two trials used similar methodology to investigate whether 
patients had a better outcome with a policy of early surgery to 
evacuate spontaneous ICH compared with initial conservative 
treatment. The STICH (Surgical Trial in Lobar Intracerebral 
Haemorrhage) included patients with supratentorial ICH of at 
least 2 cm in diameter and with a Glasgow Coma Scale (GCS) 
of at least 5.9 In STICH II (Surgical Trial in Lobar Intracerebral 
Haemorrhage), these criteria were refined to include only 
patients with a lobar hemorrhage within 1 cm of the cortex sur-
face of between 10 and 100 mL and where the Motor GCS was 
5 or 6 and the Eye score of the GCS 2 or more.11
Patients were excluded from both if there was an 
ictohemorrhagic lesion (aneurysm or arteriovenous malfor-
mation) underlying the hemorrhage, or if they had severe 
preexisting comorbidity that would mean that they could not 
achieve a Good Recovery on the Glasgow Outcome Scale 
(GOS) at 6 months even if they made a full recovery from 
the hemorrhage. Neither trial displaced the null hypothesis but 
both showed a nonsignificant benefit with surgical evacuation.
We used the combined STICH and STICH II data sets to 
investigate the relationship between outcome and the effect 
modification of variables that may influence the response to 
surgery following spontaneous ICH: neurological condition 
quantified by GCS and clot volume. We undertook standard 
meta-analysis with standard prespecified data grouping and 
supplemented this with a new nonparametric ranked analysis 
that displays the whole data set and avoids the problems of 
comparing groups with arbitrarily selective boundary criteria.
In view of the novelty of our analysis method, we 
also applied it to another data set to fully test its utility. The 
STITCH(Trauma) trial is the first and only trial on surgical evac-
uation of traumatic brain contusions (traumatic ICH) of 10 mL 
or more.10 It used a similar methodology to the STICH trials with 
no restriction in GCS. It was curtailed early because of research 
funding restrictions. One hundred seventy out of a planned 840 
cases were recruited. It also had a nonsignificant improvement in 
primary outcome with surgery but it also showed a large, statisti-
cally significant reduction in death rate in the surgical group.
Methods
The data used in this analysis will be submitted to the VISTA data-
base in the future but is available from the authors (online-only Data 
Supplement).
The first STICH trial randomized 1033 patients; STICH II ran-
domized 601; outcome was not available for 69 patients from STICH, 
18 from STICH II. A further 6 patients are lost to analyses involving 
the extended GOS (GOSE) where there was insufficient information 
to code whether the outcome was upper or lower severe disability (1 
case), upper or lower moderate disability (4 cases), or upper or lower 
good recovery (1 case). This analysis, therefore, relies on 1541 patients 
who were randomized to early surgery or initial conservative treatment.
STITCH(Trauma) randomized 170 patients and outcome was 
available for 167.
Meta-Analysis
Meta-analysis was undertaken using Review Manager (5.3). A 
dichotomized prognosis-based outcome was used to improve the 
sensitivity of the trial.19 The prognostic variables were age, GCS at 
randomization and volume of hematoma. For patients with a good 
prognosis, which was defined as a value of 27.692 or greater on the 
prognostic algorithm (10×GCS—age—[0.64×volume]), a favorable 
outcome was defined as good recovery or moderate disability on the 
GOSE and unfavorable outcome as severe disability, vegetative, or 
dead on the GOSE. For patients with a poor prognosis, a value below 
27.692 on the algorithm, favorable outcome was defined as good re-
covery, moderate disability, or upper severe disability and unfavor-
able outcome as lower severe disability, vegetative, or death. Thus, 
patients with a poor prognosis who became housebound but could be 
left alone for at least 8 hours were regarded as having a favorable out-
come. Meta-analyses are reported for all spontaneous and traumatic 
ICH patients separately and a subgroup analysis of GCS using the 
standard prespecified bandings: GCS 3–8, 9–12, and 13–15.
Ranked Analysis
Each individual was allocated ranks on the GOSE and GCS scales and 
on lesion volume so that for each scale their rank was the number of 
subjects with equal or lower values to themselves, including them-
selves. Then nonparametric regression of ranked GOSE versus another 
ranked variable was used. Lowess cubic kernel curves were fitted and 
span selected by inspection using Matlab R2015a. The simplest non-
parametric regression method is the moving average. This involves de-
ciding on a proportion of the data set to use, say for example 20%, 
and then starting at the left-hand side of the x axis and plotting the 
average of the left most 20% of data points. Then moving one data 
point right, averaging this 20% and so on across to the right hand most 
20%. The proportion of data points used, 20% in this case, is the span. 
We used local linear regression with the Lowess function but the same 
principle of span applies. Short spans give good independence between 
neighboring regions of the data set but a lot of random wiggling of 
the regression line. Long spans smooth out these wiggles but have the 
disadvantage that one region of the curve can significantly affect neigh-
boring regions and this can obscure fine details in the underlying rela-
tionship. Spans are selected by inspection to be the shortest that give 
reasonable suppression of random wiggles. For the present study spans 
were varied between 0% and 100% and the largest sensitivity of P 
values found. We plotted this relationship separately for the initial con-
servative and early surgery groups on the same graph. Bootstrapping 
was used to test the significance of the area between the lines.
The nonparametric regression lines give a visual estimate of the 
likely difference between outcomes for the treatments under considera-
tion. They can be viewed as the number of points on the outcomes scale 
that can be expected for a particular patient’s characteristics when plotted 
on the independent variable (×) scale. The limitation of nonparametric 
statistics with regard to CIs led us to analyze these differences using 
a new statistic and that is the area between the curves. This is a direct 
measure of the difference between the positions of the 2 curves summed 
over the entire range of the independent variable being considered. How 
clinically relevant this statistic is has yet to be determined as it has not 
previously been used but it is readily related to the outcome scales.
Bootstrapping is a numerical method that makes no parametric 
assumptions. It is based on deriving a distribution for the statistic under 
study by doing the above-described analysis repeatedly on the data, but 
with the distinction that instead of dividing the patients into 2 groups 
according to how they were allocated in the trials, the patients are di-
vided at random. Then after a million iterations enough area measure-
ments have been generated to create a frequency distribution of areas 
which is centered on zero and is approximately normal. This distri-
bution can then be used to compare with the area found on the initial 
data analysis and so determine what proportion of randomly generated 
areas are less than or more than the area we have found on analysis. 
This test is inherently 2-tailed because the area is not dependent on 
which of the 2 regression lines is the higher at any particular point.
We performed a sensitivity analysis to determine how sensitive the 
P values were to the robustness feature in the MATLAB Lowess func-
tion and to the selected span. In general, with short spans there is more 
random noise or wiggling in the regression curves with correspondingly 
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easily masked by these larger areas so shorter spans will lead to lower P 
values. At the other end of the spectrum, 100% span will give P values 
identical to a Wilcoxon rank-sum test unless the regressions lines cross. 
The main area of interest was in spans between 35% and 65%.
Meta-Analysis Using New Cut Points
This ranked regression system has the advantage that it can show 
when the lines cross each other, that is, when one treatment is supe-
rior over one range of a variable and the other is superior over another 
range. So, for example, we found surgery to be superior for large 
clot volumes and conservative to be superior for small. The crossing 
point of the regression lines gives the cut point between these ranges. 
These cut points could be used to identify the appropriate regions to 
use for meta-analysis bands. A further post hoc meta-analysis was 
undertaken for GCS using the new cut points identified.
Each study obtained ethical approval before randomizing any 
patients. The trial protocols were published.20–22
Results
Meta-Analysis
Figure 1A through 1D shows the results of the meta-analy-
ses. All the studies individually show a nonsignificant trend 
Figure 1. Forest plots. A, All spontaneous intracerebral hemorrhage (ICH) patients. B, All traumatic ICH patients. C, Spontaneous ICH by Scale (GCS) with 
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towards favorable outcome with surgery. Figure 1A shows 
that the combined result from meta-analysis of the sponta-
neous ICH trials gives an overall odds ratio (OR) of 0.87 
(95% CI, 0.70–1.09; P=0.23). Figure 1B shows that for trau-
matic ICH the OR is 0.57 (95% CI, 0.31–1.08; P=0.09). 
Figure 1C and 1D is the subgroup analyses looking at the 
3 bands of the GCS. There is a wide variation in the ORs 
observed for the GCS band 3 to 8 with the results dominated 
by STICH showing no treatment effect. For GCS band 13 
to 15 (the most conscious patients), the results are similar 
between the 2 studies giving a combined OR of 0.92 (95% 
CI, 0.68–1.23; P=0.56). For the intermediate GCS band 9 
to 12, both studies give similar results with the combined 
OR for the spontaneous studies is 0.70 (95% CI, 0.48–1.03; 
P=0.07). In traumatic ICH, there is a tendency for improved 
outcome with surgery in both GCS band 3 to 8 (OR, 0.50 
[95% CI, 0.11–2.38; P=0.38]) and GCS 9 to 12 band (OR, 
0.48 [95% CI, 0.18–1.26; P=0.14]) but again no treatment 
effect in GCS band 13 to 15.
Ranked Analysis
Figure 2A through 2D shows the results of the ranked 
analyses. In these graphs, all patients are located on the y 
axis according to their GOSE ranking (where GOSE varies 
Figure 2. In these figures in all cases the total population, including both early surgery and initial conservative patients are ranked according to the parameters of 
Glasgow Coma Scale (GCS) at presentation and clot volume for the x axis and Extended Glasgow Outcome Scale (GOSE) for the y axis. A case’s ranking is equal to 
the number of cases below or equal to that case in the parameter involved so that, for example, in the combined STICH I and II trials (Surgical Trial in Lobar Intracerebral 
Haemorrhage), there were 485 patients with a GOSE of 1 (died) and they were all given a ranking of 485 shown by the horizontal line. Only 2 patients had a GOSE of 2 
(vegetative) so the grid line for this outcome cannot be resolved from that for GOSE 1. The x axis is simply all patients ranked. Equal spacing on the axes equals equal 
numbers of patients. On the y axis nonparametric regression values are plotted using Matlab 8.5.0.197613 (R2015a) malowess with robustness and spans given below. 
Spans were determined by inspection. The area between the lines was used as the statistic for P value calculations. A, Data combined from the STICH and STICH II 
trials plotting ranked presenting GCS against a nonparametric regression of ranked GOSE. Span was 0.4, P=0.4. B, Data from the STITCH(Trauma) trial (Surgical Trial in 




 http://ahajournals.org by on May 8, 2019
1112  Stroke  May 2019
between 1 for dead and 8 for upper good recovery) and on 
the x axis according to their parameter ranking (GCS or 
volume). The plots are nonparametric regression of patients 
in the 2 groups: surgical and conservative. It is of interest that 
despite the combined STICH data set being much larger and 
of a different pathology to the STITCH(Trauma) data set, 
both show the same basic relationships. For presenting GCS, 
surgery may be more beneficial in an intermediate range and 
not at the extremes. Though this pattern was common to both 
data sets it was not significant for spontaneous ICH (spon-
taneous P=0.4, traumatic P=0.012). The maximum benefit 
from surgery seems to be for patients with a GCS of 10 to 13. 
For hematoma volume, surgery is detrimental for small vol-
umes and beneficial for large volumes with benefit increas-
ing the larger the volume.
Meta-Analysis Using New Cut Points
The meta-analysis of the spontaneous and traumatic ICH data 
sets undertaken using the new banding for GCS identified by 
the rank analysis is shown in Figure 3A and 3B. The OR for 
GCS band 10 to 13 in the spontaneous data set is 0.71 (95% 
CI, 0.51–1.00; P=0.05) and in the traumatic data set is 0.16 
(95% CI, 0.05–0.51; P=0.002).
Discussion
Analysis of the data from 1541 randomized and monitored 
spontaneous ICH patients suggests that patients with an inter-
mediate presenting GCS in the range of 9 to 12 may benefit 
from surgery whereas those with higher or lower GCS may 
not. This finding is consistent with surgical opinion which 
generally holds that in patients with a high GCS, the risks 
Figure 2 Continued. C, Data combined from the STICH and STICH II trials (Surgical Trial in Lobar Intracerebral Haemorrhage), plotting ranked presenting clot 
volume against nonparametric regression of ranked GOSE. Span was 0.55, P=0.042. D, Data from the STITCH(Trauma) trial (Surgical Trial in Traumatic Intra-
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of surgery are poorly justified by small potential benefit; and 
patients with a low GCS have a poor prognosis with or without 
surgery which consequently has little to offer.
The dichotomized method used for the primary analysis of 
the trials limits our ability to study how particularly GCS and 
volume interact with surgery. At the extremes of both GCS 
and volume, any effect of surgery would be expected to lie 
within the extreme ranges of the GOSE (death, upper good re-
covery) rather than between them and dichotomized outcomes 
that split the scale in the middle will not pick these up. To do 
so, we need to use the full GOSE rather than dichotomize it 
but this leads to a problem with the common method of relat-
ing variables—regression. Regression is a parametric method 
that relies on the assumption that variables are ordinal (each 
point on the scale is strictly less than the one below it and 
greater than the one above it) and uniform (and by the same 
amount). The ordinal assumption can be made for GOSE (be-
cause for each point on the scale, a patient at that point can do 
everything at the point below them plus something else) but 
not the uniform assumption.
The GCS is neither clearly ordinal nor uniform. It is made 
up of 3 subscales each of which can reasonably be regarded 
as ordinal but combining them means that it is not true that 
for every point on the GCS patients have worse coma than for 
the point above. However, in practice we consider the GCS to 
be ordinal because its corelation with outcome in large data 
sets is ordinal.
We, therefore, use a regression method based on rank 
that only requires the ordinal and not the uniform assump-
tion. Each subject is allocated a rank on the GOSE and GCS 
scales and on lesion volume. Then nonparametric regression 
of ranked GOSE versus another ranked variable is plotted.
Significance was tested with bootstrapping. Comparing 
areas under the 2 lines is related to the Wilcoxon ranked-sum 
test. This is fair in cases where the lines do not cross. Where 
they do cross it is not satisfactory because significance will 
be lost by combining a disadvantage in one region with a 
benefit in another irrespective of how large the effect is and 
whether or not it is real. Therefore, we use the statistic of 
area between the lines.
The standard meta-analysis found that patients with an in-
termediate presenting GCS in the range of 9 to 12 appeared 
to benefit from surgery whereas those with higher or lower 
GCS did not. The ranked analysis suggested that this benefit 
accrued for patients with a GCS in the range 10 to 13 and that 
this may be a better window to investigate in future trials as 
it was derived directly from the data rather than depending on 
an arbitrarily selected GCS range. The post hoc analysis con-
firmed that a GCS range of 10 to 13 identified those patients 
most likely to benefit from surgery.
Figure 3. Forest plots using new categorization of Glasgow Coma Scale (GCS; ≤9, 10–13, and 14–15). A, Spontaneous intracerebral hemorrhage (ICH) 
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For hematoma volume, the finding was of a negative effect 
of surgical evacuation at low volume passing through neu-
trality to a positive effect as volumes increased. Again this is 
consistent with surgical opinion which generally holds that the 
effect of surgery in this situation is mediated by decompression 
and that the greater the volume of clot the greater the potential 
for decompression such that at small volumes, the risk of sur-
gery is not justified but this reverses with larger volumes.
The STICH and STITCH(Trauma) trials were similar in 
design but they addressed different pathologies, in view of 
which it is striking how similar are the patterns seen in both 
with the ranked analysis. We consider that it is possible that 
this pattern reflects general principles that apply across neu-
rological conditions and neurosurgical operations. Those 
being the larger the surgical target the greater the potential 
benefit of surgery and with mild disease the risks of surgery 
outweigh the benefits. An idea for which there is also support 
from animal models.23
Limitations
The nonparametric analysis is an exploratory post hoc anal-
ysis but has been undertaken on a large data set and offers 
better hypotheses for future trials in spontaneous and trau-
matic ICH.
The P values of the ranked analysis represent the proba-
bility that allocating cases from the whole population to groups 
at random would give an area between the lines of equal to or 
greater than that obtained by allocating cases according to the 
group they were randomized to in the trials. We consider all 
these P values to be marginal. A limitation of the method we 
used is that to some extent the P value is dependent on the 
selected span. At low span, more random wiggles in the lines 
increases the area between them. This reduces the proportion 
of that area that is because of systematic differences and so 
increases P values. At high span, key features of the line such 
as the boundary and crossing positions are more prone to bias. 
The conventional method of span selection, and the one we 
used, is by inspection. Regression plots are examined and 
the lowest span which leads to a reasonable suppression of 
random scatter is selected. It should be noted, however, that 
relatively small changes in span can affect the P value so that, 
for example, in the case of Figure 2B, changing the span from 
0.55 to 0.4 changes the P value to 0.055. For this reason, we 
describe P values as marginal rather than showing definite sig-
nificance or otherwise.
Conclusions
Meta-analysis favors the hypothesis that the neutral result 
of spontaneous ICH trials is because of the mixing of sys-
tematic positive and negative effects rather than there being 
a uniform small or absent effect. We identified that patients 
with an intermediate GCS (10–13) and a large spontaneous 
ICH may be more likely to benefit from surgery and that 
this might be a more appropriate categorization of the GCS 
for future studies of ICH. Our ranked analysis method 
shows similar effects on traumatic ICH/contusion data and 
may prove to be a valuable tool in assessing the effects of 
treatments.
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